Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
In this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in...
Let us know if you enjoyed this episodeIn this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in DNA sequencing and genotyping for mice. Despite their initial unfamiliarity with the technical details, they recognize the company's significant role in pharmaceutical research. They are impressed by its financial performance, noting substantial growth in revenue and EBITDA, along with high margins. The conversation also...
Episode Transcript
More Episodes
Inside a Senior Care Franchise Doing $21M in Revenue
In this episode, the hosts review the franchise disclosure document for Comfort Keepers and debate whether senior in-home care franchising is a scalable wealth builder—or a people-management headache best left to the right operator.
$3.2M for a Dog Grooming Business?!
In this episode, the hosts analyze a $2M revenue mobile dog grooming franchise on Long Island and debate whether strong margins and recurring revenue justify the premium price—especially after franchise fees and fleet CapEx.
Buying an Excavation Business: $4.2M Revenue Deal Reviewed
In this episode, the hosts break down a 30-year-old site prep and grading business in coastal North Carolina, debating whether steady demand and durable relationships outweigh the heavy equipment CapEx risks.